H.C. Wainwright initiated coverage on Surrozen with a new price target
$SRZN
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
H.C. Wainwright initiated coverage of Surrozen with a rating of Buy and set a new price target of $32.00